Barclays’s Inhibrx, Inc. Common Stock INBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-282,303
| Closed | -$9.87M | – | 4435 |
|
|
2024
Q1 | $9.87M | Buy |
282,303
+193,438
| +218% | +$6.76M | ﹤0.01% | 1036 |
|
|
2023
Q4 | $3.11M | Buy |
88,865
+25,688
| +41% | +$898K | ﹤0.01% | 1848 |
|
|
2023
Q3 | $1.15M | Sell |
63,177
-5,357
| -8% | -$97.5K | ﹤0.01% | 1992 |
|
|
2023
Q2 | $1.76M | Buy |
68,534
+3,873
| +6% | +$99.6K | ﹤0.01% | 1817 |
|
|
2023
Q1 | $1.19M | Sell |
64,661
-41,942
| -39% | -$774K | ﹤0.01% | 2008 |
|
|
2022
Q4 | $2.56M | Buy |
106,603
+19,525
| +22% | +$469K | ﹤0.01% | 1488 |
|
|
2022
Q3 | $1.52M | Buy |
87,078
+83,981
| +2,712% | +$1.47M | ﹤0.01% | 1826 |
|
|
2022
Q2 | $38K | Sell |
3,097
-1,481
| -32% | -$18.2K | ﹤0.01% | 3845 |
|
|
2022
Q1 | $102K | Buy |
+4,578
| New | +$102K | ﹤0.01% | 3661 |
|